How much does a box of Nintedanib cost in India?
Nintedanib(Nintedanib) is a drug used to treat certain types of lung disease. It belongs to a class of drugs called multitarget tyrosine kinase inhibitors. Nintedanib is primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF) and chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease (SSc-ILD). Its working mechanism involves inhibiting the activity of several receptors, including platelet-derived growth factor receptor (PDGFR), vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR). By inhibiting these receptors, nintedanib can prevent the activation of related signaling pathways, reduce inflammation and fibrosis processes, and thereby reduce the symptoms of lung diseases.
Nintedanib produced by Indian pharmaceutical companies includes original drugs and generic drugs. The ingredients of the two drugs are basically the same, and there may be differences in drug specifications, prices, etc. For example, the price of the original Indian version of 150mg*60 capsules per box may be more than 5,000 RMB (the price may fluctuate due to the exchange rate), the price of the generic version of 150mg*30 capsules produced by India's BDR Pharmaceuticals may be around 800 RMB per box, and the price of 150mg*30 capsules produced by India's Grandmark Pharmaceuticals may be around 900 RMB (the price may fluctuate due to the exchange rate).
The original drug of nintedanib is marketed in China as nintedanib ethanesulfonate soft capsules and is covered by Class B medical insurance, but reimbursement is limited to patients who meet the indications. SpecificationsThe price of each box of 150mg*30 capsules may be more than 4,000 yuan. Nintedanib Original drug marketed overseas also has a Turkish version, specificationsThe price of each box of 100mg*60 tablets may be more than 4,000 yuan (the price may fluctuate due to the exchange rate). For more drug information and specific prices, please consult Yaode’s medical consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)